Jessica Xin Hjaltelin

Jessica Xin Hjaltelin

Assistant Professor

ORCID: 0000-0002-7878-7830

Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2022
  2. Published

    Randomized Phase II Study of Nivolumab with or Without Ipilimumab Combined with Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

    Chen, I. M., Johansen, Julia Sidenius, Theile, S., Hjaltelin, Jessica Xin, Novitski, Sif Ingibergsdóttir, Brunak, Søren, Hasselby, Jane Preuss, Willemoe, G. L., Lorentzen, T., Madsen, K., Jensen, B. V., Wilken, E. E., Geertsen, P., Behrens, C., Nolsøe, Christian, Hermann, K. L., Svane, Inge Marie & Nielsen, Dorte Lisbet, 2022, In: Journal of Clinical Oncology. 40, 27, p. 3180-3189

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report

    Al-Jaberi, F. A. H., Crone, C. G., Lindenstrøm, T., Arildsen, Nicolai Skovbjerg, Lindeløv, E. S., Aagaard, L., Gravesen, E., Mortensen, R., Andersen, A. B., Ølgaard, Klaus, Hjaltelin, Jessica Xin, Brunak, Søren, Bonefeld, Charlotte Menne, Kongsbak-Wismann, Martin & Geisler, Carsten, 2022, In: Frontiers in Immunology. 13, 9 p., 1038960.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 124409205